VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $22,968 | +114740.0% | 710 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $20 | -99.9% | 710 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $17,000 | -10.5% | 710 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $19,000 | -29.6% | 710 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $27,000 | +17.4% | 710 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $23,000 | -36.1% | 710 | -42.5% | 0.00% | -33.3% |
| Q3 2021 | $36,000 | -85.8% | 1,234 | -83.4% | 0.00% | -85.0% |
| Q2 2021 | $253,000 | – | 7,441 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |